A series of 1,3,5-triaryl-2-pyrazolines 2a-g were synthesized by the reaction of 4,4 0 -disubstituted chalcone with phenyl hydrazine. All these compounds were characterized by NMR, IR and mass spectral and single crystal XRD data. All the synthesized products were screened for their in vitro antimicrobial, analgesic and antioxidant properties. The docking studies were carried out for these compounds against the active site of methionyl-tRNA synthetase (metRS). Some of the tested compounds exhibited significant antimicrobial, analgesic, DPPH scavenging activities and molecular binding.

In the asymmetric unit of the title compound, C17H14F2N2O, there are three independent mol­ecules (A, B and C) which differ slightly in the relative orientations of the two fluoro­phenyl rings. In mol­ecules A and C one of the fluoro­phenyl rings is disordered over two positions, with occupancy ratios of 0.72 (2):0.28 (2) for mol­ecule A and 0.67 (2):0.33 (2) for mol­ecule C. The dihedral angle between the two fluoro­phenyl rings in the independent mol­ecules lie in the range 70.3 (3)–84.0 (3)°. In the crystal structure, the mol­ecules are linked via inter­molecular C—H⋯O and C—H⋯F hydrogen bonds and π⋯π stacking inter­actions [centroid–centroid distance = 3.7508 (13) Å], forming a three-dimensional network.

In the title compound, C21H16F2N2, the dihedral angle between the fluoro­phenyl groups is 66.34 (8)°, and the dihedral angle between the envelope-configured pyrazole group (N/N/C/C/C) and the benzene ring is 11.50 (9)°. The dihedral angles between the benzene and the two fluoro-substituted phenyl groups are 77.7 (6) and 16.7 (5)°. Weak C—H⋯π interactions contribute to the stability of the crystal structure.

Key indicatorsSingle-crystal X-ray study T = 120 K Mean (C-C) = 0.005 Å R factor = 0.052 wR factor = 0.127 Data-to-parameter ratio = 9.2 For details of how these key indicators were automatically derived from the article, see

In the title compound, C21H16Br2N2, the central pyrazole ring adopts an flattened envelope conformation, with the stereogenic C atom in the flap position. The deviations from planarity for this ring are relatively minor (r.m.s. deviation = 0.045 Å) and the dihedral angles formed with the N- and Cimine-bound benzene rings are 7.73 (13) and 11.00 (13)°, respectively. By contrast, the benzene ring bound at the chiral C atom is almost orthogonal to the rest of the mol­ecule; the dihedral angle formed between this ring and the pyrazole ring is 79.53 (13)°. In the crystal, the packing is stabilized by C—H⋯N and C—H⋯Br inter­actions.

The 3-cyclo­hexene units adopt envelope conformations in each of the two independent mol­ecules that comprise the asymmetric unit of the title compound, C20H16F2O3. The dihedral angles between the two fluoro­phenyl rings are 79.7 (2) and 73.7 (2)° in the two mol­ecules. In one of the mol­ecules, two C—H groups of the cyclo­hexene ring are disordered over two sets of sites in a 0.818 (13):0.182 (13) ratio, the major and minor components corresponding to the two enanti­omeric forms of the mol­ecule. Weak inter­molecular C—H⋯O inter­actions help to stabilize the crystal structure.

Key indicatorsSingle-crystal X-ray study T = 298 K Mean (C-C) = 0.007 Å R factor = 0.079 wR factor = 0.245 Data-to-parameter ratio = 22.4For details of how these key indicators were automatically derived from the article, see

Key indicatorsSingle-crystal X-ray study T = 376 K Mean (C-C) = 0.004 Å R factor = 0.035 wR factor = 0.086 Data-to-parameter ratio = 22.5 For details of how these key indicators were automatically derived from the article, see